Alberta Cancer Foundation

710 - 10123 99 St NW
Edmonton, AB T5J3H1
CEO: Myka Osinchuk
Board Chair: Angela Boehm

Charitable Reg. #: 11878 0477 RR0001
Sector: Health - Cancer
Public Foundation

Donor Accountability

Grade: B+

The grade is based on the charity's public reporting of the work it does and the results it achieves.

Financial Transparency

Audited financial statements for current and previous years available on the charity's website [ Audited financial statement for most recent year ]

Need for Funding

Funding Reserves Program Costs

Spending Breakdown

Full-time staff #58

Avg. Compensation $103,540

Top 10 Staff Salary Range

$350k + 0
$300k - $350k 0
$250k - $300k 2
$200k - $250k 2
$160k - $200k 3
$120k - $160k 3
$80k - $120k 0
$40k - $80k 0
< $40k 0
Information from most recent CRA Charities Directorate filings for F2015

About Alberta Cancer Foundation:

Founded in 1985, Alberta Cancer Foundation (ACF) is the main fundraising organization for most of Alberta’s cancer centres. The charity’s mission is to make Alberta the leader in cancer research, prevention and care. For these purposes the foundation funds research to better understand the risk factors, improve screening methods and provide better treatments. It also allocates funds to improve care and wellness services for patients suffering from cancer. ACF reports 43 new cancer cases are diagnosed every day in Alberta. 

In 2015, ACF allocated $16 million to cancer research and $5 million to treatment. Alberta Cancer Foundation gave out $6.9m to Alberta Health Services, $4.7m to University of Calgary and $4.0m to University of Alberta funding research in immunotherapy, head and neck cancer, and lung cancer.  ACF also funded a 6 years, $5m Tomorrow Project to use 50,000 biological samples to understand the root causes of cancer, and a 7 years, $9.9m project on advanced prostate screening.

Alberta Cancer Foundation reports its research funding has saved 600 lives. In 2015, key research results are ACF-funded researchers made new discoveries in lymphoma and prostate cancer treatments. Dr. John Lewis at the University of Alberta discovered a new biomarker to predict prostate cancer recurrence in treated patients. His research team recruited 889 patients for the clinical trial and started treatment on 700 patients. Dr. Douglas Stewart from the University of Calgary found that stem cell treatments improved survival rates for lymphoma patients from 45% to 65%.

Financial Review:

Alberta Cancer Foundation is one of Canada’s Major 100 charities with F2015 donations of $22.2m. Total overhead costs are 49% exceeding Ci’s reasonable range. The average for total overhead costs for Canadian charities is 26%. ACF has funding reserves of $154.6m, including $38m in donor-endowed funds. Excluding donor-endowed funds, funding reserves can cover annual program costs 6.6 times, up from 3.7 times in F2013.

For every dollar donated, 27 cents go towards research. ACF spends 74% of its program costs on research allocations.

This charity report is an update that is being reviewed by Alberta Cancer Foundation. Changes and edits may be forthcoming.

Updated on June 1st, 2016 by Mirza Ali Shakir.

Financial Ratios

Fiscal year ending March
Fundraising & admin costs as % of revenues 48.7%49.0%47.0%
Program cost coverage (%) 833.6%641.5%520.6%

Summary Financial Statements

All figures in $000s
Donations 22,15319,60518,996
Government funding 75250
Lotteries (net) 666929692
Business activities (net) 8,9888,75411,777
Investment income 13,14211,4249,868
Other income 1,7091,382163
Total revenues 46,73342,11941,497
Program costs 18,55120,84322,576
Fundraising & administrative costs 16,35015,05014,866
Cash flow from operations 11,8326,2264,054
Funding reserves 154,646133,701117,524
Note: Ci reports net revenues from lotteries, understating expenses and revenues by $4.3m in F2015, $4.3m in F2014 and $3.9m in F2013.

Comments added by the Charity:

No comments have been added by charity
Go to top